Pertussis models to inform vaccine policy

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 3, 2015, Pages 669-678

  Campbell, Patricia T ^a,b   McCaw, James M ^a,b   McVernon, Jodie ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Infectious disease dynamics; Mathematical modeling; Pertussis; Transmission; Vaccines

Indexed keywords

PERTUSSIS VACCINE;

BACTERIAL TRANSMISSION; CONTROL STRATEGY; DISEASE MODEL; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION RATE; INFECTION RESISTANCE; MASS IMMUNIZATION; PATIENT CARE; PERIODICITY; PERTUSSIS; POLICY; POPULATION DYNAMICS; PUBLICATION; REINFECTION; REVIEW; SEASONAL VARIATION; ADOLESCENT; EPIDEMIOLOGY; HEALTH CARE POLICY; IMMUNIZATION; STATISTICAL MODEL; WHOOPING COUGH; YOUNG ADULT;

ADOLESCENT; EPIDEMIOLOGIC METHODS; HEALTH POLICY; HUMANS; IMMUNIZATION SCHEDULE; MODELS, STATISTICAL; WHOOPING COUGH; YOUNG ADULT;

EID: 84928661340     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1011575     Document Type: Review

References (48)

1. Cherry JD. Pertussis: challenges today and for the future. PLoS Pathog 2013; 9:e1003418; PMID:23935481; http://dx.doi.org/10.1371/journal.ppat.1003418.
2. Jackson DW, Rohani P. Perplexities of pertussis: recent global epidemiological trends and their potential causes. Epidemiol Infect 2014; 142:672- 84; PMID:23324361; http://dx.doi.org/10.1017/S0950268812003093.
3. McIntyre P. Lessons from surveillance: solving the pertussis puzzle. N S W Public Health Bull 2003; 14:69- 71; PMID:12806403; http://dx.doi.org/10.1071/NB03022.
4. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24 (5 Suppl):S58-S61; PMID:15876927; http://dx.doi.org/10.1097/01.inf.0000160914.59160.41.
5. Lavine JS, King AA, Bjørnstad ON. Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proc Natl Acad Sci U S A 2011; 108:7259-64; PMID:21422281; http://dx.doi.org/10.1073/pnas.1014394108.
6. Riolo MA, King AA, Rohani P. Can vaccine legacy explain the British pertussis resurgence? Vaccine 2013; 31:5903-8; PMID:24139837; http://dx.doi.org/10.1016/j.vaccine.2013.09.020.
7. Rohani P, Drake JM. The decline and resurgence of pertussis in the US. Epidemics 2011; 3:183-8; PMID:22094341; http://dx.doi.org/10.1016/j.epidem.2011.10.001.
8. Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet 2006; 367:1926-36; PMID: 16765762; http://dx.doi.org/10.1016/S0140-6736(06)68848-X.
9. Cherry JD. Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis. Clin Infect Dis 1999; 28 Suppl 2:S107-11; PMID:10447027; http://dx.doi.org/10.1086/515057.
10. Teunis PFM, Van Der Heijden OG, De Melker HE, Schellekens JFP, Versteegh FGA, Kretzschmar MEE. Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiol Infect 2002; 129:479-89; PMID:12558330; http://dx.doi.org/10.1017/S0950268802007896.
11. Vynnycky E, White RG. An Introduction to Infectious Disease Modelling. Oxford: Oxford University Press, 2010.
12. Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. New York: Oxford University Press, 1991.
13. Wallinga J, Teunis P, Kretzschmar M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am J Epidemiol 2006; 164:936-44; PMID:16968863; http://dx.doi.org/10.1093/aje/kwj317.
14. Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008; 5:e74; PMID:18366252; http://dx.doi.org/10.1371/journal.pmed.0050074.
15. Rohani P, Zhong X, King AA. Contact network structure explains the changing epidemiology of pertussis. Science 2010; 330:982-5; PMID:21071671http://dx.doi.org/10.1126/science.1194134.
16. Ogunjimi B, Hens N, Goeyvaerts N, Aerts M, Van Damme P, Beutels P. Using empirical social contact data to model person to person infectious disease transmission: an illustration for varicella. Math Biosci 2009; 218:80-7; PMID:19174173; http://dx.doi.org/10.1016/j.mbs.2008.12.009.
17. Kretzschmar M, Teunis PFM, Pebody RG. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Med 2010; 7:e1000291; PMID:20585374; http://dx.doi.org/10.1371/journal.pmed.1000291.
18. de Greeff SC, Dekkers ALM, Teunis P, Rahamat-Langendoen JC, Mooi FR, de Melker HE. Seasonal patterns in time series of pertussis. Epidemiol Infect 2009; 137:1388-95; PMID:19327200; http://dx.doi.org/10.1017/S0950268809002489.
19. Broutin H, Viboud C, Grenfell BT, Miller MA, Rohani P. Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries. Proc R Soc Lond B Biol Sci 2010; 277:3239-45.
20. Dafilis MP, Frascoli F, McVernon J, Heffernan JM, McCaw JM. The dynamical consequences of seasonal forcing, immune boosting and demographic change in a model of disease transmission. J Theor Biol 2014; 361:124-32; PMID:25106793; http://dx.doi.org/10.1016/j.jtbi.2014.07.028.
21. Dafilis MP, Frascoli F, Wood JG, Mccaw JM. The influence of increasing life expectancy on the dynamics of SIRS systems with immune boosting. ANZIAM J 2012; 54:50-63; http://dx.doi.org/10.1017/S1446181113000023.
22. van Boven M, de Melker HE, Schellekens JFP, Kretzschmar M. A model based evaluation of the 1996- 7 pertussis epidemic in The Netherlands. Epidemiol Infect 2001; 127:73-85.
23. Préziosi M-P, Halloran ME. Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness. Vaccine 2003; 21:1853-61; http://dx.doi.org/10.1016/S0264-410X(03)00007-0.
24. Hethcote HW, Horby P, McIntyre P. Using computer simulations to compare pertussis vaccination strategies in Australia. Vaccine 2004; 22:2181-91; PMID:15149775; http://dx.doi.org/10.1016/j.vaccine.2003.11.053.
25. Gomes MGM, White LJ, Medley GF. Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives. J Theor Biol 2004; 228:539-49; PMID:15178201; http://dx.doi.org/10.1016/j.jtbi.2004.02.015.
26. Wearing HJ, Rohani P. Estimating the duration of pertussis immunity using epidemiological signatures. PLoS Pathog 2009; 5:e1000647; PMID:19876392; http://dx.doi.org/10.1371/journal.ppat.1000647.
27. Hethcote HW. An age-structured model for pertussis transmission. Math Biosci 1997; 145:89-136; PMID:9309930; http://dx.doi.org/10.1016/S0025-5564(97)00014-X.
28. Hethcote HW. Simulations of pertussis epidemiology in the United States: effects of adult booster vaccinations. Math Biosci 1999; 158:47-73.
29. Grenfell BT, Anderson RM. Pertussis in England and Wales: an investigation of transmission dynamics and control by mass vaccination. Proc R Soc Lond B Biol Sci 1989; 236:213-52; PMID:2567004; http://dx.doi.org/10.1098/rspb.1989.0022.
30. Van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine 2004; 22:3154-65; PMID:15297068; http://dx.doi.org/10.1016/j.vaccine.2004.01.067.
31. Luz PM, Codeço CT, Werneck GL, Struchiner CJ. A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil. Epidemiol Infect 2006; 134:850-62; PMID:16316489; http://dx.doi.org/10.1017/S095026880500539X.
32. Coudeville L, Van Rie A, Andre P. Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies. Epidemiol Infect 2008; 136:604- 20; PMID:17612417; http://dx.doi.org/10.1017/S0950268807009041.
33. van Boven M, de Melker HE, Schellekens JFP, Kretzschmar M. Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands. Math Biosci 2000; 164:161- 82; PMID:10748285; http://dx.doi.org/10.1016/S0025-5564(00)00009-2.
34. Águas R, Gonçalves G, Gomes MGM. Pertussis: increasing disease as a consequence of reducing transmission. Lancet Infect Dis 2006; 6:112-7; PMID:16439331; http://dx.doi.org/10.1016/S1473-3099(06)70384-X.
35. Roberts MG. Can we prevent the next epidemic? The elimination of childhood diseases by mass vaccination. J App Math Decision Sci 2000; 4:175-82; http://dx.doi.org/10.1155/S1173912600000134.
36. Quinn HE, Snelling TL, Macartney KK, McIntyre PB. Duration of protection after first dose of acellular pertussis vaccine in infants. Pediatrics 2014; 133:e513-9; PMID:24515514; http://dx.doi.org/10.1542/peds.2013-3181.
37. McLean AR. Vaccines and their impact on the control of disease. Br Med Bull 1998; 54:545-56; PMID:10326283; http://dx.doi.org/10.1093/oxfordjournals.bmb.a011709.
38. Blackwood JC, Cummings DAT, Broutin H, Iamsirithaworn S, Rohani P. Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand. Proc Natl Acad Sci U S A 2013; 110:9595- 600.
39. Mooi FR, de Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect Dis 2007; 7:614- 24; PMID:17537674; http://dx.doi.org/10.1016/S1473-3099(07)70113-5.
40. Hall R. Notifiable diseases surveillance, 1917 to 1991. Communicable Dis Intell 1993; 17:226-36.
41. Campbell P, McIntyre P, Quinn H, Hueston L, Gilbert GL, McVernon J. Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia. PLoS One 2012; 7:e35874; PMID:22558249; http://dx.doi.org/10.1371/journal.pone.0035874.
42. Hethcote HW. Modeling heterogeneous mixing in infectious disease dynamics. In: Isham V, Medley G, eds. Models for Infectious Human Diseases. Press Syndicate of the University of Cambridge, Cambridge, 1996:215-38.
43. Geard N, McCaw JM, Dorin A, Korb KB, McVernon J. Synthetic population dynamics: a model of household demography. J Artif Soc Social Simul 2013; 16:8.
44. Rohani P, Earn DJD, Grenfell BT. Impact of immunisation on pertussis transmission in England and Wales. Lancet 2000; 355:285-6; PMID:10675078; http://dx.doi.org/10.1016/S0140-6736(99)04482-7.
45. Lavine JS, King AA, Andreasen V, Bjørnstad ON. Immune boosting explains regime-shifts in prevaccineera pertussis dynamics. PLoS One 2013; 8:e72086.
46. Van Buynder PG, Owen D, Vurdien JE, Andrews NJ, Matthews RC, Miller E. Bordetella pertussis surveillance in England and Wales: 1995-7. Epidemiol Infect 1999; 123:403-11; PMID:10694150; http://dx.doi.org/10.1017/S0950268899003052.
47. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B, Sentinel Health Unit Surveillance System Pertussis Working Group. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001; 32:1691-7; PMID:11360208; http://dx.doi.org/10.1086/320754.
48. Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, Zell E, Martin S, Messonnier NE, Clark TA, et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics 2013; 131:e1047-e52; PMID:23478868; http://dx.doi.org/10.1542/peds.2012-1928.